SYSTEMATIC REVIEW OF REPRODUCTIVE OUTCOMES FOR WOMEN UNDERGOING FERTILITY-SPARING THERAPY WITH PROGESTIN AND METFORMIN FOR ATYPICAL ENDOMETRIAL HYPERPLASIA AND EARLY ENDOMETRIAL CANCER.

被引：0
|
作者：
Chae-Kim, Jennifer [1 ]
Garg, Gunjal [1 ]
Gavrilova-Jordan, Larisa [2 ]
Blake, Lindsay E. [3 ]
Kim, Tongil T. I. [4 ]
Hayslip, Clifford Cal, Jr. [1 ]
机构：
[1] East Carolina Univ, Greenville, NC 27858 USA
[2] Augusta Univ, Med Coll Georgia, Augusta, GA USA
[3] Univ Arkansas Med Sci, Little Rock, AR 72205 USA
[4] Emory Univ, Goizueta Business Sch, Atlanta, GA 30322 USA
来源：
FERTILITY AND STERILITY | 2020年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
O-51
引用
下载
收藏
页码：E21 / E22
页数：2
相关论文
共 50 条
  • [21] Fertility-sparing management with progestin for young women with early-stage endometrial cancer and complex hyperplasia with atypia
    Park, J.
    Roh, H.
    Jao, W.
    You, H.
    Kim, D.
    Kim, J.
    Kim, Y.
    Nam, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [22] Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential
    Pronin, Stanislav Mikhailovich
    Novikova, Olga Valerievna
    Andreeva, Julia Yurievna
    Novikova, Elena Grigorievna
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (06) : 1010 - 1014
  • [23] Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
    Fan, Yuan
    Li, Xingchen
    Wang, Jiaqi
    Wang, Yiqin
    Tian, Li
    Wang, Jianliu
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [24] Analysis of pregnancy-associated factors after fertility-sparing therapy in young women with early stage endometrial cancer or atypical endometrial hyperplasia
    Yuan Fan
    Xingchen Li
    Jiaqi Wang
    Yiqin Wang
    Li Tian
    Jianliu Wang
    Reproductive Biology and Endocrinology, 19
  • [25] Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer
    Mitsuhashi, A.
    Sato, Y.
    Kiyokawa, T.
    Koshizaka, M.
    Hanaoka, H.
    Shozu, M.
    ANNALS OF ONCOLOGY, 2016, 27 (02) : 262 - 266
  • [26] Fertility-sparing therapy for young women with endometrial cancer
    Frumovitz, Michael
    Gershenon, David M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (01) : 27 - 32
  • [27] The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review
    Piatek, Szymon
    Michalski, Wojciech
    Sobiczewski, Piotr
    Bidzinski, Mariusz
    Szewczyk, Grzegorz
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2021, 263 : 139 - 147
  • [28] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra G.
    Kahn, Jenna L.
    Shah, Divya K.
    Ko, Emily M.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 393 - 394
  • [29] Endometrial Cancer in Reproductive Age: Fertility-Sparing Approach and Reproductive Outcomes
    Mutlu, Levent
    Manavella, Diego D.
    Gullo, Giuseppe
    McNamara, Blair
    Santin, Alessandro D.
    Patrizio, Pasquale
    CANCERS, 2022, 14 (21)
  • [30] Criteria for resumption of assisted reproductive technology intervention after fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer
    Huttler, Alexandra
    Kahn, Jenna
    Shah, Divya
    Ko, Emily
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S122 - S122
12345